REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE
Technology
E-055-2021
Patent ID
E-055-2021-0-US-02
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2024-0293532-A1
Application Number
18/271,901
IC
NIAID
Date Filed
Date Issued
Patent PDF